Mirii Harada

2PUBLICATIONS
2CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 06, 2023
Small cell carcinoma of the kidney treated with immune checkpoint inhibitor/tyrosine kinase inhibitor.

Mirii Harada, Ikko Tomisaki, Shohei Shimajiri

|Jan 24, 2023
Differential impact of proton pump inhibitor on survival outcomes of patients with advanced urothelial carcinoma treated with chemotherapy versus pembrolizumab.

Ikko Tomisaki, Mirii Harada, Shigeru Sakano

Pageof 1